Dr Joseph M Chalil Global Healthcare Executive and Best Selling Author

Dr. Joseph M. Chalil is a prominent physician executive, currently serving as U.S. Country Manager & Strategic Advisor at ICHORtech GmbH and the Managing Partner at Parker Lloyd LLC. His extensive contributions to healthcare innovation and research are recognized internationally, with numerous publications in leading journals.

Dr. Chalil is currently an LLM Medical Law and Ethics candidate at the University of Edinburgh Law School, further enhancing his expertise in the intersection of healthcare, law, and ethics.

He holds key positions as the Chairman of the Complex Health Systems Advisory Board and as an Adjunct Professor at the College of Business at Nova Southeastern University, Florida. He is an author of multiple best-selling books, including India Beyond The Pandemic and  Beyond The Covid-19 Pandemic, which reflect his vision and commitment to advancing global healthcare systems.

A U.S. Navy Medical Corps veteran, Dr. Chalil is also a former strategic member of the Executive Leadership Council at the Dr. Kiran C. Patel College of Allopathic Medicine. He served as the Chief Strategic Advisor for the American Association of Physicians of Indian Origin (AAPI), advocating for the interests of Indian-origin medical professionals.

Dr. Chalil is a Fellow of the American College of Healthcare Executives and is recognized for his leadership in healthcare administration. His commitment to balanced media representation is evident as the Former Chairman of the Indo-American Press Club and as a columnist for the Sunday Guardian. He is also a regular guest on Indian TV news channels like Republic TV and NewsX, where he discusses various topics, including US-India relations, geopolitical issues, and public policy, showcasing his depth of knowledge in these areas.

His unique blend of medical, legal, and policy expertise positions Dr. Chalil as a respected figure in healthcare and media. He is admired for his contributions to patient-centered care, healthcare policy, and international relations.

In December 2025, Dr. Chalil was appointed Honorary Advisor to the Advisory Board of the Nirogya Life Line Foundation (NLLF), a not-for-profit organization serving as the lead agency in collaboration with the ICMR-Centre for Innovation and Bio-Design (CIBioD) at PGIMER Chandigarh and the Ministry of Health, India, to modernize Primary Health Centers. This role supports NLLF’s Futuristic Healthcare Delivery Ecosystem (FHDE), featuring innovative kiosks like the Tele-Master 301 for point-of-care diagnostics, specialist connectivity, and ecosystem strengthening in underserved rural and remote regions of India.

In 2025, Dr. Chalil was appointed to the Philanthropy Advisory Board of the Ron and Kathy Assaf College of Nursing at Nova Southeastern University (NSU), where he provides strategic guidance to advance nursing education and interdisciplinary healthcare training. Additionally, he serves as Chief Medical Advisor at Geneva Private Equity, offering expertise in healthcare strategy, life sciences, and biotechnology investments.

Education

Dr. Chalil completed his Bachelor of Medicine and Bachelor of Surgery from JJM Medical College, Davengere, India, in 1998. In 2004, he obtained a Master of Business Administration from Davenport University, Michigan. In the same year, he completed a certification in Pharmaceutical Management from CMR Institute. He was awarded a Fellowship by the American College of Healthcare Executives in 2009. He also completed the Global Health Delivery Certification from Harvard University in 2021.

University of Edinburgh Law School

Master of Laws – LLM Candidate in Medical Law & Ethics (2023 – 2025)

Harvard University

Harvard University (2021), Boston, MA, USA (Public Health, Global Healthcare Delivery Certification)

American College of Healthcare Executives

American College of Healthcare Executives (2009), Chicago, IL, USA (FACHE, Fellowship)

Davenport University

Davenport University (2004), Michigan, USA (MBA, Healthcare Administration)

Henry Ford Hospital

Henry Ford Hospital (2003), Detroit, MI USA (Hospital Administration Fellowship)

JJM Medical College

JJM Medical College (1998), Davengere, India (M.B.B.S., Bachelor of Medicine and Bachelor of Surgery)

Career

U.S. Country Manager & Strategic Advisor, ICHORtec GmbH
Managing Partner, Parker Lloyd LLC
Chief Medical Advisor, Geneva Private Equity, 2025–present: Provides strategic oversight in healthcare, life sciences, and biotechnology investments
Honorary Advisor, Advisory Board, Nirogya Life Line Foundation (NLLF), December 2025–present: Contributes strategic guidance to initiatives advancing accessible healthcare in India, including the deployment of FHDE kiosks validated by ICMR-CIBioD and integrated with the Ayushman Bharat Digital Mission, in partnership with the Ministry of Health
Member, Philanthropy Advisory Board, Ron and Kathy Assaf College of Nursing, Nova Southeastern University (NSU), 2025–present: Contributes to the advancement of nursing education, research, and interdisciplinary healthcare programs
Member, Advisory Board at Truvian Sciences
Clinical Advisor at Third Pole Therapeutics
Adjunct Professor and Chairman, Health System Advisory Board, College of Business & Entrepreneurship at Nova Southeastern University in Florida
Publisher of The Universal News Network and TheUNN.com
Member, Strategic Advisory Board of Psychocare Health Pvt Ltd
Former Chief Medical Officer of Novo Integrated Sciences, Inc. (NYSE: NVOS)
Former Chief Strategic Adviser, American Association of Physicians of Indian Origin (AAPI)

Dr. Joseph M. Chalil

MBBS, MBA, FACHE
Global Healthcare Executive and Best-Selling Author

Dr Joseph M Chalil Dec 23 2025
Education:
Master of Laws – LLM Candidate in Medical Law & Ethics (2023 – 2026), University of Edinburgh Law School
Public Health, Global Healthcare Delivery Certification (2021), Harvard University
FACHE, Fellowship (2009), American College of Healthcare Executives
MBA, Healthcare Administration (2004), Davenport University
Hospital Administration Fellowship (2003), Henry Ford Hospital
M.B.B.S., Bachelor of Medicine and Bachelor of Surgery (1998), JJM Medical College
Title:
  • U.S. Country Manager & Strategic Advisor, ICHORtec GmbH
  • Managing Partner, Parker Lloyd LLC
  • Member, Advisory Board at Truvian Sciences
  • Clinical Advisor at Third Pole Therapeutics
  • Adjunct Professor and Chairman, Health System Advisory Board, College of Business & Entrepreneurship at Nova Southeastern University in Florida.
  • Publisher of The Universal News Network and TheUNN.com
  • Member, Strategic Advisory Board of Psychocare Health Pvt Ltd
Awards:
Presidential Award for Leadership 2023
Selected as Top Physician of the Year for 2022
Selected as one of eight World-Class Media Influencers (2021)
Recipient of the prestigious 2015 National Presidential Award
2013 Outstanding Top 50 Asian Americans in Business Award
New York Presidential Award (2013)
Honoree (2013)
President's Club winner for 2011 and 2014
Selected for Executive in Residence Program (Cambridge, UK) (2015)
Watch More

Books, Publications and Patents

Dr. Chalil, a staunch advocate for universal healthcare access, has authored two insightful books addressing contemporary healthcare challenges. His latest work, India Beyond the Pandemic, continues his exploration into healthcare solutions by offering a comprehensive analysis of how India can navigate and recover from the COVID-19 crisis. This book builds on his previous work, Beyond the COVID-19 Pandemic, which proposed non-partisan strategies to reform U.S. healthcare. In Beyond the COVID-19 Pandemic, Chalil delves into the revolutionary potential of new technologies in healthcare, suggesting critical strategies that can be adopted globally during natural disasters, wars, or pandemics. Both books reflect Chalil’s vision for an emerging world order that prioritizes healthcare needs, education, and sustainable lifestyle choices, aiming to reduce the need for costly interventions and ultimately improve the quality of life. Together, these works provide a compelling roadmap for addressing healthcare challenges both in the U.S. and globally, especially in the wake of the pandemic.

Patents

  • United States Patent granted on January 24, 2012, to Joseph M. Chalil – Inventor – Patent No. US 8,101,469. Method of Forming Monolithic CMOS-MEMS Hybrid Integrated, Packaged Structures, 21 Claims. (The invention relates to a method of integrating MEMS and CMOS structures. Monolithic integration of MEMS/NEMS and electronics offers significant benefits, enabling high-volume production and significantly driving down the per-unit costs of sensor and actuator systems.)
  • United States Patent granted on January 24, 2012, to Joseph M. Chalil – Inventor – Patent No. US 8,101,458. Method of Forming Monolithic CMOS-MEMS Hybrid Integrated, Packaged Structures, 15 Claims.
  • United States Patent granted on August 2, 2011, to Joseph M. Chalil – Inventor – Patent No. US 7,989,248. Method of Forming Monolithic CMOS-MEMS Hybrid Integrated, Packaged Structures, 40 Claims.
  • K. Kumar, Joseph Chalil, et al. (2011): World Intellectual Property Organization International Bureau Worldwide patent No. WO2011003057A2. Procédé de formation de structures intégrées et empilées hybrides de mems cmos monolithiques
  • K. Kumar, Joseph Chalil, et al. (2011): World Intellectual Property Organization International BureauWorldwide patent No. WO2011003057A3. Procédé de formation de structures intégrées et empilées hybrides de mems cmos monolithiques
  • K. Kumar, Joseph Chalil, et al. (2009): U.S. Patent Application No. 12/547, 191. Flexible Penetrating Electrodes For Neuronal Stimulation and Recording and Method of Manufacturing Same. (The invention relates to penetrating electrodes and a method of producing flexible, penetrating multi-electrode arrays for neuronal applications.)
  • K. Kumar, Joseph Chalil, et al. (2009): U.S. Provisional Patent Application No.61/237,407. Intelligent CMOS MEMS Drug Delivery System. (The device senses intra-cardiac pressure and, depending upon the sensed pressure, directs the electronic module to deliver a specified dosage of a drug.)

Books & Publications

Dr. Chalil, a staunch advocate for universal healthcare access, has authored two insightful books addressing contemporary healthcare challenges. His latest work, India Beyond the Pandemic, continues his exploration into healthcare solutions by offering a comprehensive analysis of how India can navigate and recover from the COVID-19 crisis. This book builds on his previous work, Beyond the COVID-19 Pandemic, which proposed non-partisan strategies to reform U.S. healthcare. In Beyond the COVID-19 Pandemic, Chalil delves into the revolutionary potential of new technologies in healthcare, suggesting critical strategies that can be adopted globally during natural disasters, wars, or pandemics. Both books reflect Chalil’s vision for an emerging world order that prioritizes healthcare needs, education, and sustainable lifestyle choices, aiming to reduce the need for costly interventions and ultimately improve the quality of life. Together, these works provide a compelling roadmap for addressing healthcare challenges both in the U.S. and globally, especially in the wake of the pandemic.

India Beyond The Pandemic Featured Image 1
Beyond Covid 19 Pandemic Website Banner 1
Dr. Joseph M Chalil, Ambassador Pradeep K. Kapur, and Professor M.D. Nalapat, India Beyond The Pandemic: A sustainable path towards global quality healthcare
Pradeep Kapur and Joseph Chalil, Beyond the COVID-19 Pandemic: Envisioning a Better World by transforming the Future of Healthcare, 2020
Greenhawt M, Abrams EM, Chalil JM, et al., The Impact of Allergy Specialty Care on Health care utilization among Peanut Allergy Children in the United States, The Journal of Allergy & Clinical Immunology in Practice (2022)
Miller TA, Koppelman SJ, Chalil JM, et al., Peanut cross-contamination in randomly selected baked goods, Ann Allergy Asthma Immunol (2022)
Shaker M, Chalil JM, et al., Commercial claims costs related to healthcare resource use associated with a diagnosis of peanut allergy, Ann Allergy Asthma Immunol (2020)
Marcus Shaker, Joseph M. Chalil et al., Economic Burden of Disease Among Peanut-Allergic Children, Ann Allergy Asthma Immunol (2019)
Terri Brown-Whitehorn, Joseph M. Chalil et al., Patient Experiences Following the OLFUS VIPES Phase IIb Epicutaneous Immunotherapy Trial: A Retrospective Qualitative Study, Annals of Allergy, Asthma & Immunology (2019)
Matthew Greenhawt, Joseph M. Chalil et al., Perceptions Among Peanut-Allergic Children: A Survey, Annals of Allergy, Asthma & Immunology (2019)
Begin P, Chalil J et al., Reduction in Severity Following 12 Months of Epicutaneous Immunotherapy for Peanut Allergy, Poster presentation; IWAA 2021
Greenhawt M, Chalil J, et al., Patient and Caregiver Burden of Peanut Allergy: An Ethnographic Study, Poster presentation; PAAM 2019
Chalil J, et al., HEALTHCARE RESOURCE USE (HCRU) AND COSTS ASSOCIATED WITH PEANUT ALLERGY (P.A.), Value in Health (2019)
Pichurko, B. M., Chalil, Joseph, et al., Comparative value of single-breath diffusing capacity of carbon monoxide corrected for alveolar volume in COPD, Restrictive, and Normal individuals, American Journal of Respiratory and Critical Care Medicine (2001)
Pichurko, B., Chalil, Joseph, et al., The Significance of Cardiopulmonary Exercise Testing (CPX) on the management of Dyspnea in respiratory-impaired patients, American Journal of Respiratory and Critical Care Medicine (2002)

Awards

Presidential Award for Leadership 2023, American Association of Physicians of Indian Origin (AAPI)
Selected as Top Physician of the Year for 2022, International Association of Top Professionals (IAOTP)
Selected as one of eight World-Class Media Influencers (2021), MSP News Global
Recipient of the prestigious 2015 National Presidential Award, AAPI
2013 Outstanding Top 50 Asian Americans in Business Award, Asian American Business Development Center
New York Presidential Award (2013), AAPI Regional Conference
Honoree (2013), American Association of Cardiologists of Indian Origin (AACIO)
President's Club winner for 2011 and 2014, Boehringer Ingelheim
Selected for Executive in Residence Program (Cambridge, UK) (2015), Ashoka & Boehringer Ingelheim

References